Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T7-010-02 Phase 1/2a trial
ISRCTN16811407Phase 2Recruiting
- Sponsor
- T7 Therapeutics
- Start
- Sep 2026
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 2 trial of T7-010-02, sponsored by T7 Therapeutics. Started Sep 2026; status: recruiting.
02
Drugs
T7-010-02
Beyond the preview
Go deeper on ISRCTN16811407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN16811407.